Lemaitre Vascular (LMAT) Tops Q2 EPS by 6c

Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.23, $0.06 better than the analyst estimate of $0.17. Revenue for the quarter came in at $25.8 million versus the consensus estimate of $25.41 million.

GUIDANCE:

Lemaitre Vascular sees Q3 2017 EPS of $0.20, versus the consensus of $0.18. Lemaitre Vascular sees Q3 2017 revenue of $25.4 million, versus the consensus of $25 million.

Lemaitre Vascular sees FY 2017 EPS of $0.79, versus the consensus of $0.70. Lemaitre Vascular sees FY 2017 revenue of $101.9 million, versus the consensus of $100.6 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SanDisk upgraded at JPMorgan after investor day; shares climb